Non-Invasive Intracranial Pressure in COVID-19 Individuals

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2020

Primary Completion Date

July 15, 2021

Study Completion Date

December 15, 2021

Conditions
Intracranial Pressure
Interventions
DEVICE

The ICP monitoring will be performed in a non-invasive method developed by Brain4Care

"The ICP monitoring will be performed in a non-invasive way through the cranial deformation method developed by Brain4Care Inc.~The selected patients will be monitored until 1h/day for 7 sequential days or even discharge. The clinical outcomes such as ventilatory status will be noted (if the subject is under oxygen supplementation, using non-invasive mechanical ventilation or intubated), the ventilatory parameters during the monitorization will be analyzed in the intubated group (or those from a non-intubated group who was intubated during the seven days of hospitalization) including IFO2, CV, PEEP, driving pressure, and pressure plate as well as ventilatory asynchronies. Some changes in ventilatory parameters during monitorization will be noted. These procedures will be applied to all groups, excepted to the healthy group. This last group will be monitored only once for 30 minutes at the Federal University of São Carlos (UFSCar)."

Trial Locations (1)

05409-003

Hospital São Paulo, São Paulo

All Listed Sponsors
collaborator

Sens4care

INDUSTRY

lead

Federal University of São Paulo

OTHER

NCT04861402 - Non-Invasive Intracranial Pressure in COVID-19 Individuals | Biotech Hunter | Biotech Hunter